Annual SG&A:
$1.83B+$323.06M(+21.42%)Summary
- As of today, ONC annual SG&A is $1.83 billion, with the most recent change of +$323.06 million (+21.42%) on December 31, 2024.
- During the last 3 years, ONC annual SG&A has risen by +$840.93 million (+84.93%).
- ONC annual SG&A is now at all-time high.
Performance
ONC SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$537.91M+$78.64M(+17.12%)Summary
- As of today, ONC quarterly SG&A is $537.91 million, with the most recent change of +$78.64 million (+17.12%) on June 30, 2025.
- Over the past year, ONC quarterly SG&A has increased by +$94.18 million (+21.23%).
- ONC quarterly SG&A is now at all-time high.
Performance
ONC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$34.18B-$177.79M(-0.52%)Summary
- As of today, ONC TTM SG&A is -$34.18 billion, with the most recent change of -$177.79 million (-0.52%) on June 30, 2025.
- Over the past year, ONC TTM SG&A has dropped by -$35.83 billion (-2164.87%).
- ONC TTM SG&A is now -55845.40% below its all-time high of -$61.09 million.
Performance
ONC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
ONC Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +21.4% | +21.2% | -2164.9% |
| 3Y3 Years | +84.9% | +62.3% | -2944.2% |
| 5Y5 Years | +371.6% | +333.6% | -6484.7% |
ONC Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +84.9% | at high | +66.6% | -48.1% | at low |
| 5Y | 5-Year | at high | +371.6% | at high | +234.4% | -241.4% | at low |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% | >-9999.0% | at low |
ONC Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $537.91M(+17.1%) | $1.96B(+5.1%) |
| Mar 2025 | - | $459.27M(-9.0%) | $1.86B(+1.7%) |
| Dec 2024 | $1.83B(+21.4%) | $504.68M(+10.9%) | $1.83B(+4.9%) |
| Sep 2024 | - | $455.22M(+2.6%) | $1.74B(+5.4%) |
| Jun 2024 | - | $443.73M(+3.8%) | $1.66B(+3.0%) |
| Mar 2024 | - | $427.43M(+2.2%) | $1.61B(+6.6%) |
| Dec 2023 | $1.51B(+17.9%) | $418.38M(+14.4%) | $1.51B(+6.2%) |
| Sep 2023 | - | $365.71M(-7.4%) | $1.42B(+3.1%) |
| Jun 2023 | - | $395.03M(+20.3%) | $1.38B(+4.8%) |
| Mar 2023 | - | $328.50M(-0.4%) | $1.31B(+2.7%) |
| Dec 2022 | $1.28B(+29.1%) | - | - |
| Dec 2022 | - | $329.74M(+2.1%) | $1.28B(+1.9%) |
| Sep 2022 | - | $322.89M(-2.6%) | $1.26B(+4.5%) |
| Jun 2022 | - | $331.40M(+12.5%) | $1.20B(+9.0%) |
| Mar 2022 | - | $294.57M(-3.9%) | $1.10B(+11.4%) |
| Dec 2021 | $990.12M(+65.0%) | $306.50M(+13.8%) | $990.12M(+11.0%) |
| Sep 2021 | - | $269.23M(+15.9%) | $891.83M(+13.8%) |
| Jun 2021 | - | $232.29M(+27.6%) | $783.44M(+16.0%) |
| Mar 2021 | - | $182.11M(-12.5%) | $675.20M(+12.5%) |
| Dec 2020 | $600.18M(+54.6%) | $208.21M(+29.5%) | $600.18M(+12.1%) |
| Sep 2020 | - | $160.84M(+29.7%) | $535.32M(+11.6%) |
| Jun 2020 | - | $124.05M(+15.8%) | $479.49M(+9.6%) |
| Mar 2020 | - | $107.08M(-25.3%) | $437.69M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $388.25M(+98.7%) | $143.35M(+36.5%) | $388.25M(+22.3%) |
| Sep 2019 | - | $105.00M(+27.7%) | $317.38M(+21.5%) |
| Jun 2019 | - | $82.25M(+42.7%) | $261.20M(+16.5%) |
| Mar 2019 | - | $57.65M(-20.5%) | $224.12M(+14.7%) |
| Dec 2018 | $195.38M(+212.1%) | $72.49M(+48.5%) | $195.38M(+30.0%) |
| Sep 2018 | - | $48.82M(+8.1%) | $150.31M(+28.3%) |
| Jun 2018 | - | $45.16M(+56.2%) | $117.13M(+41.6%) |
| Mar 2018 | - | $28.91M(+5.5%) | $82.75M(+32.2%) |
| Dec 2017 | $62.60M(+211.5%) | $27.41M(+75.3%) | $62.60M(+43.8%) |
| Sep 2017 | - | $15.64M(+45.1%) | $43.52M(+33.5%) |
| Jun 2017 | - | $10.78M(+22.9%) | $32.60M(+26.7%) |
| Mar 2017 | - | $8.77M(+5.2%) | $25.73M(+28.0%) |
| Dec 2016 | $20.10M(+174.9%) | $8.34M(+76.6%) | $20.10M(+36.6%) |
| Sep 2016 | - | $4.72M(+21.0%) | $14.71M(+22.5%) |
| Jun 2016 | - | $3.90M(+24.6%) | $12.01M(+28.9%) |
| Mar 2016 | - | $3.13M(+6.2%) | $9.31M(+27.4%) |
| Dec 2015 | $7.31M(+5.5%) | $2.95M(+46.0%) | $7.31M(+22.1%) |
| Sep 2015 | - | $2.02M(+67.3%) | $5.99M(-22.9%) |
| Jun 2015 | - | $1.21M(+6.7%) | $7.77M(+18.4%) |
| Mar 2015 | - | $1.13M(-30.4%) | $6.56M(+20.9%) |
| Dec 2014 | $6.93M(+120.5%) | $1.63M(-57.2%) | $5.43M(+42.8%) |
| Sep 2014 | - | $3.80M | $3.80M |
| Dec 2013 | $3.14M | - | - |
FAQ
- What is BeOne Medicines Ltd. annual SG&A?
- What is the all-time high annual SG&A for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. annual SG&A year-on-year change?
- What is BeOne Medicines Ltd. quarterly SG&A?
- What is the all-time high quarterly SG&A for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. quarterly SG&A year-on-year change?
- What is BeOne Medicines Ltd. TTM SG&A?
- What is the all-time high TTM SG&A for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. TTM SG&A year-on-year change?
What is BeOne Medicines Ltd. annual SG&A?
The current annual SG&A of ONC is $1.83B
What is the all-time high annual SG&A for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high annual SG&A is $1.83B
What is BeOne Medicines Ltd. annual SG&A year-on-year change?
Over the past year, ONC annual SG&A has changed by +$323.06M (+21.42%)
What is BeOne Medicines Ltd. quarterly SG&A?
The current quarterly SG&A of ONC is $537.91M
What is the all-time high quarterly SG&A for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high quarterly SG&A is $537.91M
What is BeOne Medicines Ltd. quarterly SG&A year-on-year change?
Over the past year, ONC quarterly SG&A has changed by +$94.18M (+21.23%)
What is BeOne Medicines Ltd. TTM SG&A?
The current TTM SG&A of ONC is -$34.18B
What is the all-time high TTM SG&A for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high TTM SG&A is -$61.09M
What is BeOne Medicines Ltd. TTM SG&A year-on-year change?
Over the past year, ONC TTM SG&A has changed by -$35.83B (-2164.87%)